当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gestational diabetes in the first trimester: is early testing justified?
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2017-02-28 , DOI: 10.1016/s2213-8587(17)30066-9
Arianne N Sweeting , Glynis P Ross , Jon Hyett , Jencia Wong

First page of article
Most studies demonstrating the risks of gestational diabetes1 and the benefits of treatment2 are limited to women diagnosed at 24 weeks' gestation and later. Such data have provided the rationale for universal testing for gestational diabetes from 24 weeks' gestation and the revised diagnostic criteria proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG)3 and endorsed by WHO4 (diagnosis based on one or more of the following: fasting plasma glucose 5·1–6·9 mmol/L, 1 h post-load glucose ≥10·0 mmol/L, 2 h post-load glucose 8·5–11·0 mmol/L following a 2 h 75 g oral glucose tolerance test).


中文翻译:

妊娠中期妊娠糖尿病:早期检测是否合理?



文章首页
大多数表明妊娠糖尿病1的风险和治疗2的益处的研究仅限于在妊娠24周及以后被诊断出的女性。这些数据为从妊娠24周起进行妊娠糖尿病的通用检测提供了依据,并为国际糖尿病和妊娠研究小组(IADPSG)3提出并经WHO 4认可的经修订的诊断标准提供了诊断(基于以下一项或多项诊断:下列情况:空腹血糖5·1-6·9 mmol / L,负荷后≥10·0 mmol / L 1 h,负荷2 h后2 h血糖8·5-11·0 mmol / L h 75克口服葡萄糖耐量试验)。
更新日期:2017-08-10
down
wechat
bug